$3.10
▼ -0.6% Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X
Incannex Healthcare Receives US Patent for IHL-42X in Obstructive Sleep Apnea
Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea
Overview
52-week range
$2.49
$50
1% of range
Avg surprise (last 2)
+44.8%
Avg reaction (last 2)
-29.8%
50% positive
Latest IV / EM
581%
EM ±133.0% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.35 | $-0.60 | +41.7% | -45.8% | +2.1% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $-0.02 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.02 | — | — | — | — | financials |
| Thu May 15, 2025 | Mar/2025 | $-0.24 | $-0.46 | +47.8% | — | -61.6% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-0.33 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.29 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.38 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.33 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.08 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $12,000 | $74,000 | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-7M | $-7M | — | $-5M | $-5M | $-6M | — |
| Net income | $-4M | $-7M | $-6M | — | $-4M | $-6M | $-5M | — |
| EPS (diluted) | $-0.35 | $-0.02 | $-0.02 | — | $-6.19 | $-0.33 | $-0.29 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $74M | $69M | $73M | $15M | $7M | $2M | $4M | $6M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $80M | $75M | $78M | $20M | $16M | $11M | $15M | $16M |
| Total assets | $80M | $75M | $79M | $20M | $16M | $11M | $16M | $17M |
| Long-term debt | — | — | — | — | — | $2M | — | — |
| Total liabilities | $5M | $2M | $2M | $7M | $9M | $10M | $9M | $6M |
| Total equity | $75M | $73M | $77M | $13M | $7M | $964,000 | $7M | $11M |